Your browser doesn't support javascript.
loading
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
Lobo, João; Ohashi, Riuko; Amin, Mahul B; Berney, Daniel M; Compérat, Eva M; Cree, Ian A; Gill, Anthony J; Hartmann, Arndt; Menon, Santosh; Netto, George J; Raspollini, Maria R; Rubin, Mark A; Tan, Puay Hoon; Tickoo, Satish K; Tsuzuki, Toyonori; Turajlic, Samra; Zhou, Ming; Srigley, John R; Moch, Holger.
Affiliation
  • Lobo J; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), Porto, Portugal.
  • Ohashi R; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (GEBC CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (P.CCC), Porto, Portugal.
  • Amin MB; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal.
  • Berney DM; Histopathology Core Facility, Niigata University Faculty of Medicine, Niigata, Japan.
  • Compérat EM; Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Cree IA; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, USA.
  • Gill AJ; Department of Urology, University of Southern California, Los Angeles, CA, USA.
  • Hartmann A; Centre for Molecular Oncology, Barts and the London School of Medicine and Dentistry, London, UK.
  • Menon S; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France.
  • Netto GJ; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
  • Raspollini MR; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Rubin MA; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.
  • Tan PH; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, NSW Health Pathology, St Leonards, New South Wales, Australia.
  • Tickoo SK; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Tsuzuki T; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Turajlic S; Department of Pathology, University of Alabama, Birmingham, AL, USA.
  • Zhou M; Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.
  • Srigley JR; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Moch H; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Histopathology ; 81(4): 426-438, 2022 Oct.
Article in En | MEDLINE | ID: mdl-35596618
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Adenoma, Oxyphilic / Kidney Neoplasms Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Histopathology Year: 2022 Type: Article Affiliation country: Portugal
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Adenoma, Oxyphilic / Kidney Neoplasms Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Histopathology Year: 2022 Type: Article Affiliation country: Portugal